I think there was a criticism—and correct me, if I'm wrong—about the way some of the funding takes place in your own school. Some of the pharmaceutical companies will come in with 50% of the funding for the research, and then they own the results and they take it wherever they see fit.
Do you have an issue with that, or is that just a frustrating reality as a research chair?